This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

34/100

✓ Peer-reviewed alzhub usefulness score 34 out of 100. Treatments

Topic: Amyloid, tau and blood-test diagnosis

Are amyloid-targeting monoclonal antibodies safe and effective for mild cognitive impairment (MCI) or Alzheimer disease? Randomized controlled trials (RCTs) of monoclonal antibodies for patients with dementia or MCI found no clinically meaningful improvements in cognitive scores. These medications

Key findings

Are amyloid-targeting monoclonal antibodies safe and effective for mild cognitive impairment (MCI) or Alzheimer disease?
Randomized controlled trials (RCTs) of monoclonal antibodies for patients with dementia or MCI found no clinically meaningful improvements in cognitive scores.

Why it matters

This review of randomized controlled trials of monoclonal antibodies for patients with dementia or mild cognitive impairment found no clinically meaningful improvements in cognitive scores. It directly addresses whether amyloid-targeting monoclonal antibodies are safe and effective for these patients.

New to this subject? Start with our plain-English guide: Treatments →

Study details

Evidence strengthHigh

How this study scored 34/100

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it.

Component	Points	Why
Journal tier	7 / 10	Tier 3 — peer-reviewed journal (Canadian Family Physician)
Journal's citation record	0 / 4	Canadian Family Physician: journal h-index 25 (OpenAlex, 2026-10-29)
Study design	0 / 12	No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence	5 / 5	Rated “high” in our summary
Peer-review validation	10 / 10	Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent	5 / 5	2026 — within 1 year(s) of the newest study here
Sample size	0 / 4	Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported	0 / 3	No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people	0 / 3	Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded	0 / 2	No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited	0 / 7	Cited 0 times (OpenAlex, 2026-10-10)
Citations per year	0 / 5	0.0 citations a year over 2 year(s) since 2026
Impact for its field and year	0 / 6	Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here	0 / 6	No other study in this library cites it
Still being cited	0 / 4	Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record	2 / 4	Last-listed author Christina S. Korownyk: h-index 27 (OpenAlex, whole career)
Institution's track record	1 / 3	University of Alberta: institution h-index 1,174 (OpenAlex)
Multi-centre collaboration	0 / 3	OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed	2 / 2	Indexed in PubMed (PMID 42128656)
Free to read	2 / 2	Free to read
Total	34 / 100	—

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Kolber, M. R., & Korownyk, C. S. (2026). Treating dementia with brain amyloid medications. Canadian Family Physician. https://doi.org/10.46747/cfp.7205330

Vancouver

Kolber MR, Korownyk CS. Treating dementia with brain amyloid medications. Canadian Family Physician. 2026. doi:10.46747/cfp.7205330. PMID: 42128656.

BibTeX

@article{kolber2026-42128656,
  author  = {Kolber, Michael R. and Korownyk, Christina S.},
  title   = {{Treating dementia with brain amyloid medications}},
  journal = {Canadian Family Physician},
  year    = {2026},
  doi     = {10.46747/cfp.7205330},
  pmid    = {42128656},
  url     = {https://doi.org/10.46747/cfp.7205330}
}

Related studies in Treatments

Also in Treatments

166 studies in the library are filed under Treatments with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Treatments hub.

Similar studies

More on Treatments

See all studies in Treatments →